Heart surgery showdown: which fix best unblocks the heart?
NCT ID NCT03877731
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 100 people with hypertrophic cardiomyopathy, a condition where the heart muscle thickens and blocks blood flow. Researchers compared different surgical techniques—removing part of the thickened heart muscle alone or combined with repairing the mitral valve—to see which best relieves symptoms and keeps patients out of the hospital. The goal is to find the most effective surgery for this heart problem.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
surgery (septal myectomy with or without mitral valve repair)
What this could lead to
If successful, this could identify the best surgical approach to relieve heart blockage and improve survival without hospital readmission for people with hypertrophic cardiomyopathy.
What could go wrong
This is a completed observational study with 100 participants, not a large randomized trial. Results may not apply to all patients, and surgery carries risks like infection or heart complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardiology research institute, National Research Medical Center of the Russian Academy of Sciences
Tomsk, 634012, Russia